Background One of the major challenges remaining in the classification of thyroid tumor is
the determination of whether a nodule is benign or malignant. We aimed to characterize the …

TERT promoter mutations (TERT-p mutations) have been found in many types of cancer and
have emerged to play critical roles in tumor progression. The mutations upregulate TERT …

BRAFV600E mutation is highly prevalent in patients with papillary thyroid carcinoma (PTC),
and TERT promoter (TERTp) mutation is strongly associated with cancer‐related mortality …

A unique prognostic role of the genetic duet of BRAF V600E and TERT promoter mutations
in papillary thyroid cancer (PTC) has been recently established, but the role of RAS mutation …

Background The genomic and transcriptomic landscape of widely invasive follicular thyroid
carcinomas (wiFTCs) and Hürthle cell carcinoma (HCC) are poorly characterized, and …

Simple Summary Hepatocellular carcinoma (HCC) is a deadly form of liver cancer that has
poor patient outcomes and survival. Unlike many other cancers, HCC has not seen the …

In recent years, thyroid malignances have become more prevalent, especially among
women. The most common sporadic types of thyroid tumors of follicular origin include …

Papillary thyroid carcinoma (PTC) represents a heterogeneous disease with diverse clinical
outcomes highlighting a need to identify robust biomarkers with clinical relevance. We …

Poorly differentiated thyroid carcinoma (PDTC) is an aggressive form of thyroid cancer that
currently has limited effective treatment options. Immune checkpoint inhibitors (ICIs) have …

Objective Genetic testing is increasingly used to diagnose or rule out thyroid cancer in
indeterminate fine-needle aspirations. This review evaluates the usefulness of these …